SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-082297
Filing Date
2004-05-07
Accepted
2004-05-07 17:23:46
Documents
4
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004 d10q.htm 10-Q 390994
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8526
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8877
4 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 7000
  Complete submission text file 0001193125-04-082297.txt   417196
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 04790249
SIC: 2834 Pharmaceutical Preparations